GlaxoSmithKline

Seretide allows asthma and chronic obstructive pulmonary disease (COPD) patients to control their condition and achieve things they would not normally manage. An exhibition stand incorporating meeting spaces, interactive information points and the latest medical research helped GSK promote the benefits of Seretide at the European Society of Paediatric Endocrinology held at the Glasgow SECC.